SHARE
COPY LINK

EBOLA

Dane admitted to hospital for Ebola testing

A patient who has recently been in west Africa was being tested for Ebola on Tuesday evening, with test results first expected during the course of the day on Wednesday.

Dane admitted to hospital for Ebola testing
This marks the third patient tested for Ebola at Hvidore Hospital in the past five weeks. The others tested negative. Photo: Hvidore Hospital
A Dane who recently returned from west Africa was admitted to Hvidore Hospital on Tuesday afternoon on the suspicion of carrying the Ebola virus, the hospital has announced. 
 
“We determined that there were grounds to admit the patient and we have sent a test to the State Serum Institute,” hospital spokesman Toben Mogensen said in a statement. 
 
The patient was put in isolation late on Tuesday and will remain there until the test results return. An initial result was expected to arrive overnight on Tuesday and a secondary sample will be sent for testing on Wednesday morning. 
 
The current patient is the third to be seen at the suburban Copenhagen hospital for suspected Ebola over the past five weeks. The other patients tested negative
 
“We’ve been through this before and we have the procedures and security under control. So our employees and patients do not need to worry about the risk of Ebola. It is not dangerous to be admitted to, or work at, Hvidore Hospital," Mogensen said. 
 
Speaking to broadcaster DR, Mogensen said that the patient was not an international aid worker, but no additional information was given. 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

EBOLA

Ebola tests sold to Denmark recalled

The US Food and Drug Administration said that Ebola kits sent to Denmark and other countries could result in "life-threatening" false positives.

Ebola tests sold to Denmark recalled
Photo: Colourbox
US regulators have issued an international recall for a 10-minute Ebola blood test made by a California-based company, saying it has not been proven to work and could put lives at risk.
 
"A recall has been issued for the LuSys Laboratories, Inc., Ebola Virus One-Step Test Kits because the FDA has not cleared or approved the kits for use or sale," said the Food and Drug Administration in a statement emailed to reporters on Thursday.
 
"The results obtained from these test kits have not demonstrated to be accurate and should not be used as in vitro diagnostic tests for Ebola infection."
 
The recall was initially issued in mid-March and applies to test kits exported to Denmark, Sierra Leone and Canada between October 2014 and January 2015.
 
The FDA did not say how many tests were sent out.
 
The recall is described as a Class I, "the most serious type of recall and involve(s) situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death," the FDA said.
 
"A false positive result may be life-threatening by potentially placing the patient in an isolation cohort with Ebola-infected patients."
 
Contacted by AFP, a company representative in San Diego said early trials have shown the test to be 86 percent accurate.
 
The problem with the FDA came down to a labeling error, he said. The equipment had not been properly labeled "for research purposes only."
SHOW COMMENTS